NDC 42291-300-18 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42291-300
- Requested NDC
- 42291-300-18
- Package NDCs from labels
- 42291-300-50, 42291-300-18
- Manufacturer
- AvKARE
- Effective date
- 2022-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - AvKARE | AvKARE | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42291-300-10 | EA - Each | 42291-300 | 5c2871aa-905f-41a6-bbd1-b1d511795efb | 1 | 2013-02-13 |
| 42291-300-18 | EA - Each | 42291-300 | f93a8097-a3fc-4094-9928-1d8dc1f4b3ff | 1 | 2013-02-13 |
| 42291-300-27 | EA - Each | 42291-300 | bbdabb19-ab3b-431f-bd23-0835bfba9a64 | 1 | 2013-02-13 |
| 42291-300-50 | EA - Each | 42291-300 | 4cd07640-6393-40d1-a357-e3afd2c2a6af | 1 | 2018-10-11 |
| 42291-300-90 | EA - Each | 42291-300 | 0243b5bf-5396-4442-8e56-5f5cd79a41e2 | 1 | 2013-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 7ddc7d92-9076-41cf-97ed-d9f9edc80298 | 2026-07-15 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 72729513-bd34-44f5-9f62-297ed25c4442 | 2026-07-15 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | f31172a2-0ae9-49f2-b797-b26fe33f3f64 | 2026-07-15 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | b6db5ce9-bd4b-420d-88a7-df9d46144c81 | 2026-07-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 9b175f8d-7667-4bfe-8bb5-fd7441eed456 | 2026-07-08 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 4ddcdff5-8f1f-bff3-e063-6294a90a1195 | 2026-07-07 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | HAWAII REPACK, INC. | f6ff265b-569b-4f5c-8fdb-00b7ad4aac7c | 2026-07-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | Sun Pharmaceutical Industries, Inc. | c9a05f0c-b5f0-422c-9d67-6d0efc921a74 | 2026-07-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Strides Pharma Science Limited | 43b67ae3-ac6f-48f5-8788-9ead08376864 | 2026-07-02 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 9d401e54-d4f5-43ba-b898-dd08fc3c7bfa | 2026-07-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gralise | GABAPENTIN | Almatica Pharma LLC | 466273b1-c9fc-3930-c94b-aa11394d5140 | 2026-06-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | HAWAII REPACK, INC. | 14d61caa-17ce-4fa2-90fb-1470f3864be8 | 2026-06-26 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 2bc65375-77b8-1e50-e063-6294a90acf8f | 2026-06-26 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | ba4d863d-be38-8cf5-e053-2995a90a69fb | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | c85ae572-9893-629e-e053-2995a90a23fc | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Zhejiang Yongtai Pharmaceutical Co., Ltd | f1eda6cc-d9b2-4df4-a09b-20eebded760f | 2026-06-25 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 55292235-bf8f-46d0-e063-6294a90a91a5 | 2026-06-25 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54ecc64b-f019-9fcb-e063-6294a90a00af | 2026-06-23 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54edd6f3-06c7-a0c7-e063-6394a90a8b4f | 2026-06-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Teva Pharmaceuticals, Inc. | c7f21eaa-68ee-420c-9c98-e997cc73a297 | 2026-06-23 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.